Myovant Sciences Ltd. was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 55.3%.

The company has seen one positive estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Myovant Sciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Myovant Sciences currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Another player in the Medical - Biomedical and Genetics industry, which looks attractive at current levels is Aravive, Inc. (ARAV Quick QuoteARAV - Free Report) , which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>